Plenary Keynote Sessions

Monday, August 24

Solving Today’s Challenges

1:35 Chairperson’s Remarks

John Sterling, MA, Editor in Chief, Genetic Engineering & Biotechnology News (GEN)

1:40 BioTechnology Product Development: Meeting Today’s Challenges While Planning for Tomorrow

Nicholas Warne, PhD, Vice President, Pharmaceutical Research and Development, BioTherapeutics Pharmaceutical Sciences, Pfizer Inc.

2:05  Speaker to be Announced

Wednesday, August 26

Leading to Tomorrow’s Advances

1:50 Chairperson’s Remarks

Dominic Clarke, PhD, ISCT Process & Product Committee; Co-Chair and Global Head, Cell Therapy, HemaCare Corp.

1:55 Scaling Cell and Gene Therapy: Challenges and Opportunities in Process Development and Manufacturing

Susan Fugett Abu-Absi, PhD, Senior Vice President, Pharmaceutical Development & Technology, bluebird bio, Inc.

2:20 The Future of Gene Therapy Technical Development

James Warren, PhD, Vice President, Pharmaceutical Development; Leader, Biotechnology and Gene Therapy Development, Ultragenyx Pharmaceutical

Premier Sponsors: